Belrapzo Injection
Product Images NDC 42367-521

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Belrapzo (NDC 42367-521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eagle Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Belrapzo 01)

Chemical structure of bendamustine hydrochloride, the active ingredient in BELRAPZO injection. The diagram shows the molecular arrangement with carbon, nitrogen, chlorine atoms, and other functional groups as part of the compound structure.*

FDA Label Image

Figure 1 (Belrapzo 02)

A line chart depicting progression-free survival over months comparing two treatments: bendamustine hydrochloride and chlorambucil. The x-axis represents time in months, and the y-axis shows survival distribution function, with two distinct survival curves for each treatment group.*

FDA Label Image

Carton Label (Belrapzo 03)

BELRAPZO 100 mg/4 mL (bendamustine HCl injection) box label for a multi-dose vial, Rx only. The label shows the Eagle Pharmaceuticals logo and includes storage instructions and mandatory dilution and administration details. The product contains 25 mg/mL concentration and is intended for intravenous injection. The NDC 42367-521-25 is displayed along with barcodes and a QR code.*

FDA Label Image

Vial Label (front) (Belrapzo 04)

Label for BELRAPZO (bendamustine HCl injection) 100 mg/4 mL (25 mg/mL) multi-dose vial by Eagle Pharmaceuticals, Inc. The label includes storage instructions, a dilution warning requiring a 500 mL admixture, and directions for intravenous infusion only. It also notes the product is sterile, refrigerated, and made in Italy.*

FDA Label Image

Vial Label (inside Of Front Label) (Belrapzo 05)

Packaging label for BELRAPZO 100 mg/4 mL (25 mg/mL) bendamustine hydrochloride injection, an intravenous infusion by Eagle Pharmaceuticals, Inc. The label includes dosage form, strength, storage instructions (2 to 8°C), a cytotoxic agent warning, and a requirement to dilute the dose in a 500 mL infusion bag of specific solutions prior to administration. The label also displays the product NDC 42367-521 and manufacturer details.*

FDA Label Image

Carton Label (Belrapzo 06)

Label for BELRAPZO (bendamustine hydrochloride) injection 100 mg/4 mL (25 mg/mL) multi-dose vial. The label states it is sterile, Rx only, and for intravenous infusion. It instructs to store refrigerated at 2 to 8°C and to dilute prior to administration in a 500 mL admixture. Marketed by Eagle Pharmaceuticals, Inc, product of India. The label includes warnings about dilution and storage conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.